About Us
The Oxford Parkinson's Disease Centre (OPDC) is a unique multidisciplinary research program at the University of Oxford. The OPDC was established in February 2010 and brings together internationally-renowned scientists who work on the genetics of Parkinson’s, the generation of cell and animal models, and the wiring of brain circuits which control movement, with clinical experts in the diagnosis and treatment of Parkinson’s.
Our world-class research centre works to understand the earliest events in the development of Parkinson’s with an ultimate view to target the molecular mechanisms of disease with neuroprotective therapies to prevent disease onset or delay progression.
Our program is focused on the molecular pathways to Parkinson’s in order to:
- Predict the onset of Parkinson’s
- Understand the progression of Parkinson’s
- Identify potential drug targets for Parkinson's
- Develop new treatments that will prevent the development of Parkinson’s in at-risk individuals.
Watch the video below to learn more about OPDC's research:
Latest News
Latest publications
Injected extracellular vesicles and other nanoparticles hitchhike on erythrocytes and platelets from circulation towards organ clearance
Journal article
Pavlova S. et al, (2026), Extracellular Vesicle, 7
Contrasting Effects of Chronic Glucokinase Activation and Inhibition on Pancreatic Beta-Cell Function.
Journal article
Lloyd M. et al, (2026), FASEB J, 40
Era of Sugammadex: A Paradigm Shift in Airway Management.
Journal article
Hagberg CA. et al, (2026), Anesthesiology, 144, 978 - 997
Biological and Genetic Definitions of Sex Versus Gender Identity in Perioperative Research: Linguistic Controversies and Implications for Healthcare.
Journal article
Pandit JJ., (2026), Anesth Analg
Hypoxic regulation of chromatin and gene transcription.
Journal article
Kindrick JD. et al, (2026), Commun Biol
Retraction Note: Multisensory learning binds neurons into a cross-modal memory engram.
Journal article
Okray Z. et al, (2026), Nature

